IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
+8.05%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$312M
AUM Growth
+$312M
(+7.5%)
Cap. Flow
+$16.1M
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
30.51%
Holding
172
New
9
Increased
35
Reduced
70
Closed
2
Top Buys
| 1 |
Apple
AAPL
|
$13.1M |
| 2 |
Novo Nordisk
NVO
|
$2.29M |
| 3 |
Camden National
CAC
|
$1.61M |
| 4 |
Sanofi
SNY
|
$785K |
| 5 |
Qualcomm
QCOM
|
$381K |
Top Sells
| 1 |
Microsoft
MSFT
|
$718K |
| 2 |
CRISPR Therapeutics
CRSP
|
$630K |
| 3 |
JPMorgan Chase
JPM
|
$418K |
| 4 |
Intel
INTC
|
$392K |
| 5 |
Diageo
DEO
|
$392K |
Sector Composition
| 1 | Technology | 21.57% |
| 2 | Healthcare | 18.18% |
| 3 | Consumer Staples | 13.78% |
| 4 | Industrials | 11.86% |
| 5 | Financials | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Caterpillar
CAT
$196B
| $3.69M | 1.18% |
24,769
-465
| -2% | -$69.3K |
|
27
Illinois Tool Works
ITW
$77.1B
| $3.67M | 1.18% |
18,986
-398
| -2% | -$76.9K |
|
28
Chevron
CVX
$324B
| $3.56M | 1.14% |
49,481
+860
| +2% | +$61.9K |
|
29
3M
MMM
$82.8B
| $3.54M | 1.14% |
22,118
-35
| -0.2% | -$5.61K |
|
|
30
Novo Nordisk
NVO
$251B
| $3.54M | 1.13% |
50,918
+32,989
| +184% | +$2.29M |
|
31
Watsco
WSO
$16.3B
| $3.53M | 1.13% |
15,144
-688
| -4% | -$160K |
|
32
GSK
GSK
$79.9B
| $3.48M | 1.12% |
92,500
+3,730
| +4% | +$140K |
|
33
AbbVie
ABBV
$372B
| $3.44M | 1.1% |
39,260
-175
| -0.4% | -$15.3K |
|
34
PepsiCo
PEP
$204B
| $3.42M | 1.1% |
24,680
+132
| +0.5% | +$18.3K |
|
35
Estee Lauder
EL
$33B
| $3.41M | 1.09% |
15,607
-152
| -1% | -$33.2K |
|
36
Lockheed Martin
LMT
$106B
| $3.12M | 1% |
8,144
+115
| +1% | +$44.1K |
|
37
Thermo Fisher Scientific
TMO
$186B
| $2.88M | 0.92% |
6,533
-76
| -1% | -$33.6K |
|
38
TJX Companies
TJX
$152B
| $2.71M | 0.87% |
48,640
-425
| -0.9% | -$23.7K |
|
39
Akamai
AKAM
$11.3B
| $2.69M | 0.86% |
24,291
+345
| +1% | +$38.1K |
|
|
40
CRISPR Therapeutics
CRSP
$4.71B
| $2.63M | 0.84% |
31,430
-7,535
| -19% | -$630K |
|
41
Baxter International
BAX
$12.7B
| $2.57M | 0.82% |
31,985
-600
| -2% | -$48.2K |
|
42
American Water Works
AWK
$28B
| $2.57M | 0.82% |
17,710
-195
| -1% | -$28.3K |
|
43
IBM
IBM
$227B
| $2.38M | 0.76% |
19,559
+2,425
| +14% | +$295K |
|
44
NVIDIA
NVDA
$4.24T
| $2.31M | 0.74% |
4,273
-90
| -2% | -$48.7K |
|
45
Novartis
NVS
$245B
| $2.31M | 0.74% |
26,563
-100
| -0.4% | -$8.7K |
|
|
46
Camden National
CAC
$692M
| $2.27M | 0.73% |
75,190
+53,210
| +242% | +$1.61M |
|
47
Chubb
CB
$110B
| $2.27M | 0.73% |
19,555
-85
| -0.4% | -$9.87K |
|
48
Duke Energy
DUK
$95.3B
| $2.21M | 0.71% |
24,956
-225
| -0.9% | -$19.9K |
|
49
McDonald's
MCD
$224B
| $2.17M | 0.69% |
9,871
-150
| -1% | -$32.9K |
|
50
Nike
NKE
$114B
| $2.05M | 0.66% |
16,301
-347
| -2% | -$43.6K |
|